An interventional study of Smoking and Health Telehealth Intervention 1 and Smoking and Health Telehealth Intervention 2 in Tobacco Smoking, sponsored by Binghamton University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by Binghamton University · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to develop two health-focused interventions for tobacco smokers with chronic pain. The main questions it aims to answer are:
This study has two phases. First, researchers will develop materials and receive feedback through three focus groups, updating the materials iteratively between each group. Next, researchers will compare the feasibility and acceptability of the two interventions.
Participants in the second phase will:
264 studies on the registry are indexed under Tobacco Smoking; 42 are open to participants now.
This study's planned enrollment of 78 is below the median of 119 across 229 interventional studies indexed under Tobacco Smoking.
Browse Tobacco Smoking studies →Binghamton University is the lead sponsor of 12 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Smoking and Health Telehealth Intervention 1
Behavioral: Smoking and Health Telehealth Intervention 2
The Smoking and Health Telehealth Intervention 1 provides educational information about how smoking is related to health and resources for smoking cessation. The intervention is delivered via live telehealth online in a single (30 minute) session.
The Smoking and Health Telehealth Intervention 2 provides educational information about how smoking is related to health and resources for smoking cessation. The intervention is delivered via live telehealth online in a single (30 minute) session.
Recruitment Feasibility
Enroll \>80% or more of people who meet eligibility criteria.
Time frame: At the participant level, time from screening through enrollment is anticipated to be up to 4 weeks. The total will be calculated at the end of the entire enrollment period of the study, which is anticipated to be approximately 1 year and 9 months.
Intervention Delivery Feasbility
Delivery of the allocated intervention to at least 95% of enrolled participants.
Time frame: At the participant level, intervention delivery occurs in the same session as enrollment. Overall feasibility will be assessed at the end of the entire enrollment period, which is anticipated to be 1 year and 9 months.
Acceptability
Mean scores for each item on the Client Satisfaction Questionnaire (CSQ) of 3 or greater. Mean total CSQ score of 24 or greater.
Time frame: Immediately post intervention (at the end of the intervention session).
Cessation Motivation
Separate ratings of motivation, importance, readiness, and confidence in quitting smoking on a scale from 0 (none) to 10 (100%).
Time frame: Assessed immediately before and after the intervention (during the interventions session), and at 2-weeks, 1-month, and 3-months after the intervention session
Motivation for Cessation Treatment
Self-reported (yes/no) willingness to learn about cessation treatments and accept cessation resources, and intention to use cessation treatments.
Time frame: Assessed immediately before and after the intervention (during the interventions session), and at 2-weeks, 1-month, and 3-months after the intervention session
Cessation Treatment Engagement
Self-reported (yes/no) use of cessation treatment.
Time frame: 2-week, 1-month, 3-month follow-up
Pain and Smoking Inventory
The Pain and Smoking Inventory measures the extent to which people believe their smoking and pain are related.
Time frame: Assessed immediately before and after the intervention (during the interventions session), and at 2-weeks, 1-month, and 3-months after the intervention session
Pain and Smoking Questionnaire
The Pain and Smoking Questionnaire measures the extent to which participants can correctly identify known associations between smoking and multiple health conditions.
Time frame: Assessed immediately before and after the intervention (during the interventions session), and at 2-weeks, 1-month, and 3-months after the intervention session
Plan to share: Yes — De-identified self-report measures will be submitted to the National Institute of Mental Health Data Archive (NDA) at the National Institutes of Health.
Access criteria: Individuals will request access to the data via a data access request through the data archive.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Binghamton University